Neutral
Arcus Biosciences (RCUS) Moves 7.8% Higher: Will This Strength Last?
Arcus Biosciences (RCUS) stock rose 7.8% on impressive volume due to investor confidence in its pipeline candidates for cancer. Despite this, the comp...